Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The long-term efficacy of new combination drug therapies for
human immunodeficiency virus infection
may be limited by the tendency of transfected human immunodeficiency virus to mutate to drug-resistant forms. This argues for the use of safe antimutagenic measures as adjuvants to such therapies. Certain nutrients and food factors-notably
selenium
, green-tea polyphenols, and cruciferous phytochemicals-can suppress cancer initiation and mutagenesis in animal and cell culture models; epidemiological studies suggest that ambient variations in consumption of these food factors can have an important impact on human cancer rates. Low-fat diets may reduce deoxyribonucleic acid base damage in human leukocytes, whereas increased body iron stores are likely to increase mutation rates. Thus, ample but safe intakes of
selenium
, green-tea polyphenols, and cruciferous vegetables, in the context of a diet low in fat and assimilable iron, can be expected to prolong the efficacy of drug therapy in subjects infected with the human immunodeficiency virus. These measures can also be recommended for cancer prevention in the general population.
...
PMID:natural antimutagenic agents may prolong efficacy of human immunodeficiency virus drug therapy. 914 Aug 84
Serum
selenium
levels were determined cross-sectionally in 57
HIV
-infected patients who were classified according to the Centers for Disease Control (CDC) 1993 classification system. Mean serum
selenium
levels were lower in CDC stage II (58.7 +/- 12.2 micrograms/L; p < 0.01; n = 18) and stage III (47.6 +/- 11.3 micrograms/L; p < 0.01; n = 19)
HIV
-infected patients, than in healthy subjects (80.6 +/- 9.6 micrograms/L; n = 48) and stage I patients (73.6 +/- 16.5 micrograms/L; n = 20). Serum
selenium
levels were positively correlated with CD4 count, CD4/8 ratio, hematocrit, and serum albumin (r = 0.42; r = 0.39; r = 0.48; and r = 0.45; p < 0.01, respectively) and inversely with serum levels of thymidine kinase (r = -0.49; p < 0.01; n = 49) and beta 2-microglobulin (r = -0.46; p < 0.001; n = 49). In addition, serum
selenium
levels in 20 randomly selected AIDS-free individuals (CDC I: n = 10; CDC II: n = 10) were inversely correlated with serum concentrations of interleukin-8 (IL-8) and soluble tumor necrosis factor receptors (sTNFR) types I and II. There was no correlation with serum immuneglobulin A and total serum protein levels. The results show that the progressive deprivation of serum
selenium
in
HIV
-infection is associated with loss of CD(4+)-cells and with increased levels of markers of disease progression and inflammatory response.
...
PMID:Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. 915 10
The genomes of both bacteria and eukaryotic organisms are known to encode selenoproteins, using the UGA codon for seleno-cysteine (SeC), and a complex cotranslational mechanism for SeC incorporation into polypeptide chains, involving RNA stem-loop structures. These common features and similar codon usage strongly suggest that this is an ancient evolutionary development. However, the possibility that some viruses might also encode selenoproteins remained unexplored until recently. Based on an analysis of the genomic structure of the human immunodeficiency virus
HIV
-1, we demonstrated that several regions overlapping known
HIV
genes have the potential to encode selenoproteins (Taylor et al. [31], J. Med. Chem. 37, 2637-2654 [1994]). This is provocative in the light of overwhelming evidence of a role for oxidative stress in AIDS pathogenesis, and the fact that a number of viral diseases have been linked to
selenium
(Se) deficiency, either in humans or by in vitro and animal studies. These include
HIV
-AIDS, hepatitis B linked to liver disease and cancer, Coxsackie virus B3, Keshan disease, and the mouse mammary tumor virus (MMTV), against which Se is a potent chemoprotective agent. There are also established biochemical mechanisms whereby extreme Se deficiency can induce a proclotting or hemorrhagic effect, suggesting that hemorrhagic fever viruses should also be examined for potential virally encoded selenoproteins. In addition to the RNA stem-loop structures required for SeC insertion at UGA codons, genomic structural features that may be required for selenoprotein synthesis can also include ribosomal frameshift sites and RNA pseudoknots if the potential selenoprotein module overlaps with another gene, which may prove to be the rule rather than the exception in viruses. One such pseudoknot that we predicted in
HIV
-1 has now been verified experimentally; a similar structure can be demonstrated in precisely the same location in the reverse transcriptase coding region of hepatitis B virus. Significant new findings reported here include the existence of highly distinctive glutathione peroxidase (GSH-Px)-related sequences in Coxsackie B viruses, new theoretical data related to a previously proposed potential selenoprotein gene overlapping the
HIV
protease coding region, and further evidence in support of a novel frameshift site in the
HIV
nef gene associated with a well-conserved UGA codon in the 1-reading frame.
...
PMID:Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. 915 12
Selenium
is a nutritionally essential trace element that is important for optimal function of the immune system. It is incorporated into selenoproteins as the amino acid selenocysteine and it is known to inhibit the expression of some viruses. In this study, we show that
selenium
supplementation for 3 days prior to exposure to tumor necrosis factor alpha (TNF-alpha) partially suppresses the induction of human immunodeficiency virus type 1 (HIV-1) replication in both chronically infected T lymphocytic and monocytic cell lines. In acute
HIV
-1 infection of T lymphocytes and monocytes in the absence of exogenous TNF-alpha, the suppressive effect of
selenium
supplementation was not observed. However,
selenium
supplementation did suppress the enhancing effect of TNF-alpha on
HIV
-1 replication in vitro in acutely infected human monocytes, but not in T lymphocytes.
Selenium
supplementation also increased the activities of the selenoproteins, glutathione peroxidase (GPx) and thioredoxin reductase (TR), which serve as cellular antioxidants. Taken together, these results suggest that
selenium
supplementation may prove beneficial as an adjuvant therapy for AIDS through reinforcement of endogenous antioxidative systems.
...
PMID:Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro. 933 49
To determine the independent contribution of specific immunologic and nutritional factors on survival in
HIV
-1 disease, CD4 cell count, antiretroviral treatment, plasma levels of vitamins A, E, B6, and B12 and minerals
selenium
and zinc were considered in relation to relative risk for
HIV
-related mortality. Immune parameters and nutrients known to affect immune function were evaluated at 6-month intervals in 125
HIV
-1-seropositive drug-using men and women in Miami, FL, over 3.5 years. A total of 21 of the
HIV
-1-infected participants died of
HIV
-related causes during the 3.5-year longitudinal study. Subclinical malnutrition (i.e., overly low levels of prealbumin, relative risk [RR] = 4.01, p < 0.007), deficiency of vitamin A (RR = 3.23, p < 0.03), vitamin B12 deficiency (RR = 8.33, p < 0.009), zinc deficiency (RR = 2.29.1, p < 0.04), and
selenium
deficiency (RR = 19.9, p < 0.0001) over time, but not zidovudine treatment, were shown to each be associated with
HIV
-1-related mortality independent of CD4 cell counts <200/mm3 at baseline, and CD4 counts over time. When all factors that could affect survival, including CD4 counts <200/mm3 at baseline, CD4 levels over time, and nutrient deficiencies were considered jointly, only CD4 counts over time (RR = 0.69, p < 0.04) and
selenium
deficiency (RR = 10.8, p < 0.002) were significantly associated with mortality. These results indicate that
selenium
deficiency is an independent predictor of survival for those with
HIV
-1 infection.
...
PMID:High risk of HIV-related mortality is associated with selenium deficiency. 934 57
Cardiac-related death of
HIV
-positive patients is not rare. The etiology of AIDS-associated dilated cardiomyopathies often remains unknown, even at autopsy. We report an observation associated to a severe deficit in
selenium
. The patient had been diagnosed as
HIV
-positive 2 years before. He presented Pneumocystis carinii pneumonia then Cryptococcus meningitis. Two months later he was hospitalized for pancreatitis and cachexia. He presented global heart failure that lead to death. No microorganism was found in myocardium at autopsy but plasma
selenium
was dramatically decreased (24 micrograms/L). The deficit in
selenium
has been associated to a dilated cardiomyopathy in non-AIDS patients.
HIV
-positive patients have an early decrease in plasma
selenium
, this concentration is dramatically decreased in malnourished patients.
Selenium
deficit might be the cause of some of the AIDS-related dilated cardiomyopathies and
selenium
supplementation might be useful in these patients.
...
PMID:[Dilated cardiomyopathy and selenium deficiency in AIDS. Apropos of a case]. 936 39
Nutritional deficiencies may contribute to immune dysregulation, and have been shown to be sensitive markers of
HIV
-1 disease progression. Only limited information exists, however, regarding the nutritional profile of
HIV
-1-seropositive drug abusers. Immune and nutritional measurements were obtained in a subsample of 125 subjects from a larger cohort of drug users being followed for
HIV
-1 infection and cofactors of disease progression. Nutritional deficiencies, particularly vitamins A, E, and zinc, were widespread with up to 86% of the drug users exhibiting at least one nutritional alteration. Although immune parameters (CD4 count, CD8 count, beta2-microglobulin) were similar in the
HIV
-1-infected men and women, women had significantly poorer overall nutritional status, as measured by plasma proteins, which are considered to be sensitive markers of malnutrition. A comparison of individuals with advanced disease (CD4 count <200/mm3) revealed significantly lower levels of plasma prealbumin (p < .01),
selenium
, (p < .05), and greater deficiency of vitamins A (p < .01) and E (p < .05) in women than in men. The greater severity of nutritional deficiencies noted in
HIV
-1-infected women may be an important determinant of disease progression and survival.
...
PMID:HIV-1 infection in women is associated with severe nutritional deficiencies. 940 74
Increased lipid peroxidation induced by reactive oxygen species may play a role in the stimulation of
HIV
replication. In this study we compared lipid peroxidation indexes and plasma antioxidant micronutrients between 49 nonsmoking
HIV
-positive patients with no active opportunistic infection (25 asymptomatic and 24 with AIDS) and 15 age-matched seronegative control subjects. Breath-alkane output, plasma lipid peroxides, antioxidant vitamins, and trace elements were measured. Vitamin C (40.7 +/- 3.02 compared with 75.7 +/- 4.3 mumol/L, P < 0.005), alpha-tocopherol (22.52 +/- 1.18 compared with 26.61 +/- 2.60 mumol/L, P < 0.05), beta-carotene (0.23 +/- 0.04 compared with 0.38 +/- 0.04 mumol/L, P < 0.05), and
selenium
(0.37 +/- 0.05 compared with 0.85 +/- 0.09 mumol/L, P < 0.005) concentrations were significantly lower in the
HIV
-positive patients. Lipid peroxides (50.7 +/- 8.2 compared with 4.5 +/- 0.8 mumol/L, P < 0.005), breath pentane (9.05 +/- 1.23 compared with 6.06 +/- 0.56 pmol.kg-1.min-1, P < 0.05), and ethane output (28.1 +/- 3.41 compared with 11.42 +/- 0.55 pmol.kg-1.min-1, P < 0.05) were significantly higher in the
HIV
-positive patients. These results showed an increase in oxidative stress and a weakened antioxidant defense system in
HIV
-positive patients. Whether supplementation of antioxidant vitamins will reduce this oxidative stress is still unknown.
...
PMID:Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. 970 Dec
Selenium deficiency has been demonstrated to be a significant predictor of
HIV
-related mortality, independent of CD4 over time, CD4 < 200 at baseline, and antiretroviral treatment. Although
selenium
deficiency in healthy humans is relatively rare (Cohen et al. 1989, Lockitch, 1989), a number of studies have documented a decline in plasma
selenium
levels and decreased glutathione peroxidase activity in individuals with
HIV
/AIDS (Dworkin et al. 1988, Cirelli et al. 1991, Mantero-Atienza et al. 1991, Staal et al. 1992, Allavena et al. 1995). These findings are of particular concern in light of
selenium
's influence on immune function, viral replication, and survival. As recent investigations (Delmas-Beauvieux et al. 1996) indicate that supplementation with
selenium
may help to increase the enzymatic defense systems in
HIV
-infected patients, further studies to determine possible mechanisms and clinical trials to evaluate the effect of
selenium
supplementation on HIV disease progression are essential.
...
PMID:Micronutrient status in relationship to mortality in HIV-1 disease. 948 Nov 35
In
HIV
infected patients, the increase of the concentration of free radicals is related to: a depletion of protective system (glutathione peroxidase, superoxide dismutase, vitamin E,
selenium
...), and an increased production of free radicals (superoxide anion, hydrogen peroxide, hydroxil radical) consecutive to the activation of lymphocytes and phagocyting cells, the chronic inflammation, the increased polyinsatured fatty acids concentration and lipoperoxidation, and direct or indirect effect of several pathologic agents including Mycoplasma sp. This free radical excess could impair cell membranes and generate apoptosis, the main cause of lymphocytes CD4+ depletion. After a brief review of the free radicals synthesis pathway, their potential deleterious effects and the protective systems, the role of free radicals in the pathogenesis of
HIV infection
are discussed in regard to data reported in the literature.
...
PMID:[Free radicals and HIV infection]. 975 55
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>